Fluvastatin suppresses native and recombinant human P2X4 receptor function

Purinergic Signalling

Volumn 8, Issue 2, 2012, Pages 311-316

  Li, Jing ^a   Fountain, Samuel J ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

ATP; Cholesterol; Inflammation; P2X receptor; Statin

Indexed keywords

CHOLESTEROL; FLUINDOSTATIN; HYPOCHOLESTEROLEMIC AGENT; MESSENGER RNA; PURINERGIC P2X2 RECEPTOR; PURINERGIC P2X4 RECEPTOR;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; ELECTROPHYSIOLOGY; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; MONOCYTE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTICHOLESTEREMIC AGENTS; DOWN-REGULATION; FATTY ACIDS, MONOUNSATURATED; HEK293 CELLS; HUMANS; INDOLES; MONOCYTES; PURINERGIC ANTAGONISTS; RECEPTORS, PURINERGIC P2X4; RECOMBINANT PROTEINS;

EID: 84860998306     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-011-9289-9     Document Type: Article

References (19)

1. Scandinavian Simvastatin Survival Study Group (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344: 1383-1389.
2. Scalia R et al (2001) Simvastatin exerts both anti-inflammatory and cardioprotective effects in apolipoprotein E-deficient mice. Circulation 103: 2598-2603.
3. Pruefer D et al (2002) Simvastatin inhibits inflammatory properties of Staphylococcus aureus α-toxin. Circulation 106: 2104-2110.
4. Østerud B, BjÈ-Rklid E (2003) Role of monocytes in atherogenesis. Physiol Rev 83: 1069-1112.
5. North RA (2002) Molecular physiology of P2X receptors. Physiol Rev 82: 1013-1067.
6. Wang L, Jacobsen SE, Bengtsson A, Erlinge D (2004) P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cells. BMC Immunol 5: 16.
7. Qureshi OS, Paramasivam A, Yu JCH, Murrell-Lagnado RD (2007) Regulation of P2X4 receptors by lysosomal targeting, glycan protection and exocytosis. J Cell Sci 120: 3838-3849.
8. Sim JA, Park CK, Oh SB, Evans RJ, North RA (2007) P2X1 and P2X4 receptor currents in mouse macrophages. Br J Pharmacol 152: 1283-1290.
9. Tsuda M, Shigemoto-Mogami Y, Koizumi S, Mizokoshi A, Kohsaka S, Salter MW, Inoue K (2003) P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424: 778-783.
10. Ulmann L, Hirbec H, Rassendren F (2010) P2X4 receptors mediate PGE2 release by tissue-resident macrophages and initiate inflammatory pain. EMBO J 29: 2290-2300.
11. Priel A, Silberberg SD (2004) Mechanism of ivermectin facilitation of human P2X4 receptor channels. J Gen Physiol 123: 281-293.
12. Fountain SJ, North RA (2006) A C-terminal lysine that controls human P2X4 receptor desensitization. J Biol Chem 281: 15044-15049.
13. Wareham K, Vial C, Wykes RCE, Bradding P, Seward EP (2009) Functional evidence for the expression of P2X1, P2X4 and P2X7 receptors in human lung mast cells. Br J Pharmacol 157: 1215-1224.
14. Vial C, Evans RJ (2005) Disruption of lipid rafts inhibits P2X1 receptor-mediated currents and arterial vasoconstriction. J Biol Chem 280: 30705-30711.
15. Allsopp RC, Lalo U, Evans RJ (2010) Lipid raft association and cholesterol sensitivity of P2X1-4 receptors for ATP. J Biol Chem 285: 32770-32777.
16. Liu M, Huang W, Wu D, Priestley JV (2006) TRPV1, but not P2X3, requires cholesterol for its function and membrane expression in rat nociceptors. Eur J Neurosci 24: 1-6.
17. Jones CA, Chessell IP, Simon J, Barnard EA, Miller KJ, Michel AD, Humphrey PPA (2000) Functional characterization of the P2X4 receptor orthologues. Br J Pharmacol 129: 388-394.
18. Barth K, Weinhold K, Guenther A, Linge A, Gereke M, Kasper M (2008) Characterization of the molecular interaction between caveolin-1 and the P2X receptors 4 and 7 in E10 mouse lung alveolar epithelial cells. Int J Biochem Cell Biol 40: 2230-2239.
19. Hillyard DZ, Jardine AG, McDonald KJ, Cameron AJM (2004) Fluvastatin inhibits raft dependent Fc[gamma] receptor signalling in human monocytes. Atherosclerosis 172: 219-228.